Clinical Trial Update: Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KN046 in patients with advanced non-small cell lung cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KN046

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Advanced Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING